Policy | August 05, 2021
NPPA issues notice to manufacturers and importers of knee implants
The data should be submitted by August 12th 2021
The data should be submitted by August 12th 2021
Robust demand for the product across the Middle East, Africa and Latin America
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
The country has constantly worked with the spirit of public-private partnership
Subscribe To Our Newsletter & Stay Updated
